ARETE BIOSCIENCES
Medtech · Private
Point-of-care molecular test for active Hepatitis C Virus (HCV) detection using nucleic acid amplification
- Grants
- $307K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $995K
- 2 awards · Health and Human S
- #321 of 4531 in medtech
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Rapid Acceleration Of Diagnostics (radx) Program Tech | $250,000 | |
| Federal contract | Department of Health and Human Services · Dev Of An Ultra-sensitive And Cost-effective Home-based Disposable Molecular Platform For SARS-COV-2 Testing Arete Biosciences Aoi #4.1 COVID-19 | $745,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care. | $306,992 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 318 | BIOWAVE CORP | $1.0M | $1.7M |
| 319 | ZETROZ SYSTEMS LLC | $1000K | — |
| 320 | Caregility Corp | $997K | $7.5M |
| 321 | ARETE BIOSCIENCES | $995K | — |
| 322 | CROSSLIFE TECHNOLOGIES INC. | $966K | — |
| 323 | SHOULDER INNOVATIONS, INC. | $966K | $81M |
| 324 | Securisyn Medical, LLC | $958K | $11M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Timed System for Rapid Assayapplication
- Methods for Analyzing Nucleic Acidsapplication
- Methods and Reagents for Analyzing Nucleic Acidsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.